Internal Medicine, Gastroenterology · Charleston, WV
NPI
1609905462
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3100 Maccorkle Ave SE Ste 500
Charleston, WV, 25304
Phone (304) 342-0821
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
1,407 services
Medicare patients, 2024
786
Average age 72
Drug cost, 2024
$3.7M
2,844 prescriptions
Company payments, 2025
$1,557
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy R Stapleton was code 99214 (office e&m - established), 354 times for 284 patients. In total Jeremy R Stapleton billed 1,407 services in 43 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 354 | 284 | $75.85 | $27K |
| 43239 Upper GI Endoscopy | Facility | 210 | 205 | $83.53 | $18K |
| 45385 Colonoscopy - Lesion Removal | Facility | 174 | 173 | $169.42 | $29K |
| 43450 Digestive/Gastrointestinal | Facility | 83 | 79 | $28.49 | $2,365 |
| 99213 Office E&M - Established | Office | 76 | 71 | $47.78 | $3,632 |
| 45380 Lower GI Endoscopy - Other | Facility | 63 | 62 | $121.70 | $7,667 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 62 | 62 | $165.35 | $10K |
| 99222 Hospital E&M - Initial | Facility | 52 | 49 | $93.10 | $4,841 |
| 76981 Ultrasound - Nonspecific | Office | 51 | 48 | $57.86 | $2,951 |
| 99204 Office E&M - New | Office | 32 | 32 | $98.15 | $3,141 |
| 99214 Office E&M - Established | Facility | 30 | 29 | $77.37 | $2,321 |
| 43235 Upper GI Endoscopy | Facility | 24 | 24 | $72.17 | $1,732 |
| 45378 Lower GI Endoscopy - Other | Facility | 17 | 16 | $132.11 | $2,246 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 16 | 16 | $171.59 | $2,745 |
| 99232 Hospital E&M - Subsequent | Facility | 12 | 12 | $60.59 | $727 |
By year: 2022 $251K for 2,717 services; 2023 $196K for 2,077 services; 2024 $133K for 1,407 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy R Stapleton prescribed most often to Medicare patients was Pantoprazole Sodium, with 487 prescriptions and refills. In total Jeremy R Stapleton wrote 2,844 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 487 | 1,338 | 188 | $6,514 |
| Omeprazole Generic | 188 | 522 | 73 | $3,031 |
| Ondansetron Hcl Generic | 161 | 168 | 64 | $2,836 |
| Famotidine Generic | 155 | 404 | 56 | $2,081 |
| Sucralfate Generic | 150 | 206 | 62 | $12K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 118 | 127 | 37 | $4,681 |
| Dicyclomine Hcl Generic | 107 | 185 | 42 | $3,699 |
| Linzess Linaclotide | 80 | 192 | 24 | $102K |
| Promethazine Hcl Generic | 70 | 95 | 24 | $2,277 |
| Stelara Ustekinumab | 68 | 107 | Under 11 | $1.8M |
| Mesalamine Er Mesalamine | 65 | 158 | 21 | $26K |
| Prednisone Generic | 57 | 59 | 24 | $306 |
| Azathioprine Generic | 57 | 123 | 11 | $2,069 |
| Humira(Cf) Pen Adalimumab | 54 | 61 | Under 11 | $439K |
| Ondansetron Odt Ondansetron | 50 | 62 | 17 | $1,301 |
Brand drugs: - claims; generic drugs: 2,238 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy R Stapleton $1,557 ($1,557 in general payments such as food, travel and fees) from 13 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $452.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 24 | $452 |
| Pfizer Inc. PFE | 18 | $312 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $205 |
| Abbvie Inc. ABBV | 10 | $136 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $106 |
| Ardelyx, Inc. ARDX | 5 | $79 |
| Gilead Sciences, Inc. GILD | 3 | $64.01 |
| QOL Medical, LLC | 2 | $55.91 |
| Aimmune Therapeutics, Inc. | 2 | $37.01 |
| Novo Nordisk Inc NVO | 2 | $35.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.